Newsfeeds - Spark Newswire

1 minute read

Cathie Wood’s ARK Invest Posts Fund Purchases For Tuesday, Aug. 10, 2021: DKNG, ETSY, ADPT, BEAM, SMFR, SGFY, PATH, SRNG, TSP, FATE, Z, VUZI, SPFR, MKFG, LPSN, BLDE, KTOS

Today, 6:53 AM

DraftKings (DKNG) - 35,900 Shares Etsy (ETSY) - 8,800 Adaptive Biotechnologies (ADPT) - 268,463 Beam Therapeutics (BEAM) - 48,616 Sema4 (SMFR) - 201,832 Signify Health (SGFY) - 308,074 UiPath (PATH) -

ADPT

2 minute read

Curebase, Adaptive Biotechnologies Announce Collaboration To Expand Clinical Study Access

By Benzinga Newsdesk

Today, 6:53 AM

Curebase, a company committed to democratizing access to clinical studies, and Adaptive Biotechnologies Corp. (NASDAQ:ADPT), a biotechnology company that aims to translate the genetics of the adaptive immune system into

ADPT

1 minute read

Goldman Sachs Maintains Neutral on Adaptive Biotechnologies, Lowers Price Target to $52

By Benzinga Newsdesk

Today, 6:53 AM

Goldman Sachs maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Neutral and lowers the price target from $59 to $52.

ADPT

7 minute read

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

By Shanthi Rexaline

Today, 6:53 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)

ABSI

1 minute read

Adaptive Biotechnologies Revises FY21 Sales Guidance From $145M-$155M To $148M-$155M vs $150.16M Est.

By Bill Haddad

Today, 6:53 AM

Adaptive Biotechnologies expects full year 2021 revenue to be in the range of $148 million to $155 million, representing 54% growth at the mid-point of the range over full year 2020 revenue. This compares to Adaptive

ADPT

1 minute read

Adaptive Biotechnologies Q2 EPS $(0.35) Beats $(0.42) Estimate, Sales $38.50M Beat $31.26M Estimate

By Bill Haddad

Today, 6:53 AM

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.42) by 16.67 percent. This is a 34.62 percent decrease over losses of $(0.26) per

ADPT

2 minute read

Movers

Unusual Options Activity Insight: Adaptive Biotechnologies

By Benzinga Insights

Today, 6:53 AM

Adaptive Biotechnologies (NASDAQ:ADPT) shares experienced unusual options activity on Wednesday. The stock price moved up to $37.34 following the option alert.

ADPT

24 minute read

Earnings Scheduled For August 4, 2021

By Benzinga Insights

Today, 6:53 AM

Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.

ABC

1 minute read

Adaptive Biotechnologies Highlights Inclusion In Abstracts At ASCO And EHA 2021

By Bill Haddad

Today, 6:53 AM

Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, will be

ADPT

2 minute read

Uncategorized

Cathie Wood Piles Up Palantir For Third Day In A Row, Adding $39M Worth Of Shares

By Rachit Vats

Today, 6:53 AM

Cathie Wood-led Ark Investment Management on Wednesday snapped up 2.07 million shares, worth about $39 million, in Palantir Technologies Inc (NYSE: PLTR), on a day the stock reversed the earnings-driven gains of the previous session.

ADPT